ARCHIVES

Six Institutions Get Awards For LAK-IL-2 Trials

This article is from The Cancer Letter archive.

Vol. 12 No. 06 | February 7, 1986

Download PDF Visit The Full Archive

Related Articles

Fadlo Khuri Named Editor-in-Chief Of ACS Journal Cancer

August 12, 2011

Phase III Regorafenib Trial Meets Endpoint Improving Progression-Free Survival

April 27, 2012

HPV Vaccine Cervarix Active In 100% Of Women In Study

July 27, 2007

As patients worry about COX-2 inhibitors, scientists and FDA review toxicity data.

October 22, 2004

Cancer Groups Criticize FDA For Ignoring Expert Advice.

November 24, 2000

Mozobil Plus G-CSF Increases Rate Of Cell Mobilization

September 30, 2005